MMP14 and Insulin resistance: Interestingly, this MT1-MMP inhibitor has been shown to characterize an invasive macrophage phenotype within the arterial wall [31] and to protect from metabolic inflammation and insulin resistance in vivo when overexpressed in macrophages [32].